Illumina's Next Big Move: Distributed Diagnostics [The Motley Fool]
Adaptive Biotechnologies Corporation (ADPT)
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adhc.com
Company Research
Source: The Motley Fool
Illumina's Next Big Move: Distributed Diagnostics Maxx Chatsko (TMFBlackn) Author Bio Maxx has been a contributor to Fool.com since 0. He graduated from the State University of New York College of Environmental Science and Forestry (0) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (0) with a Master of Science in Materials Science & Engineering. In recent years, investors have loudly cheered big announcements from DNA sequencing leader Illumina NASDAQ:ILMN $,000 human genome But the latest trajectory-altering move doesn't seem to be getting nearly the same attention. Illumina has been inking partnerships across and beyond the genomics industry to provide customers and competitors access to its global base of installed machines. Whether Illumina co-develops novel in vitro diagnostic (IVD) test kits or simply allows established tests to use its instruments, the goal is the same: to improve patient outcomes with distributed diagnostics. Here's wh
Show less
Read more
Impact Snapshot
Event Time:
ADPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADPT alerts
High impacting Adaptive Biotechnologies Corporation news events
Weekly update
A roundup of the hottest topics
ADPT
News
- Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target raised by analysts at Piper Sandler from $6.00 to $7.00. They now have an "overweight" rating on the stock.MarketBeat
- Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies Reports Third Quarter 2024 Financial ResultsGlobeNewswire
- Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell LymphomaGlobeNewswire
- Earnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 Result [Yahoo! Finance]Yahoo! Finance
ADPT
Earnings
- 11/7/24 - Beat
ADPT
Analyst Actions
- 10/2/24 - BTIG
ADPT
Sec Filings
- 11/19/24 - Form 4
- 11/13/24 - Form SC
- 11/13/24 - Form SC
- ADPT's page on the SEC website